Illumina Sees Significant Decrease in Short Interest (ILMN)
Illumina (NASDAQ:ILMN) saw a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 17,710,485 shares, a decline of 11.9% from the April 30th total of 20,100,661 shares, AnalystRatings.Net reports. Approximately 14.0% of the shares of the company are sold short. Based on an average daily volume of 1,263,753 shares, the short-interest ratio is currently 14.0 days.
In other Illumina news, CEO Jay Flatley unloaded 30,000 shares of the stock in a transaction dated Thursday, May 22nd. The shares were sold at an average price of $154.95, for a total transaction of $4,648,500.00. Following the completion of the sale, the chief executive officer now directly owns 381,262 shares in the company, valued at approximately $59,076,547. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.
A number of analysts have recently weighed in on ILMN shares. Analysts at Ned Davis Research upgraded shares of Illumina from a “sell” rating to a “neutral” rating in a research note on Monday, April 28th. Separately, analysts at Maxim Group upgraded shares of Illumina from a “hold” rating to a “buy” rating in a research note on Wednesday, April 23rd. They now have a $205.00 price target on the stock. Finally, analysts at Bank of America reiterated a “buy” rating on shares of Illumina in a research note on Wednesday, April 23rd. They now have a $195.00 price target on the stock. Eight analysts have rated the stock with a hold rating, seven have given a buy rating and one has issued a strong buy rating to the company. Illumina has a consensus rating of “Buy” and an average target price of $144.34.
Illumina (NASDAQ:ILMN) opened at 158.68 on Tuesday. Illumina has a 52-week low of $66.11 and a 52-week high of $183.30. The stock has a 50-day moving average of $145.6 and a 200-day moving average of $137.7. The company has a market cap of $20.374 billion and a P/E ratio of 111.29.
Illumina (NASDAQ:ILMN) last announced its earnings results on Tuesday, April 22nd. The company reported $0.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.45 by $0.01. The company had revenue of $421.00 million for the quarter, compared to the consensus estimate of $391.50 million. During the same quarter in the previous year, the company posted $0.46 earnings per share. The company’s revenue for the quarter was up 27.2% on a year-over-year basis. Analysts expect that Illumina will post $2.16 EPS for the current fiscal year.
Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.